SCHEMBL28800056

SCHEMBL28800056

CC(C)c1ccc(C=CCS(=O)(=O)n2c(C(O)c3cccc(C(=O)O)c3)cc3cc(Cl)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACLY P53396 4/20 0.41
▸ CCR2 P41597 1/20 0.39
▸ PHGDH O43175 5/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ NPC1 O15118 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ NFKB2 Q00653 1/20 0.35
▸ RELA Q04206 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CSNK2A2 P19784 1/20 0.34
▸ CSNK2B P67870 1/20 0.34
▸ CSNK2A1 P68400 1/20 0.34
▸ CSNK2A3 Q8NEV1 1/20 0.34
▸ MRGPRX4 Q96LA9 1/20 0.34
▸ PPARG P37231 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27867731 0.85 CCR2 (0.43) ACLYCCR2PHGDHMRGPRX4PPARG
SCHEMBL12096936 0.83 ACLY (0.52) ACLYCCR2PHGDHCA1CA2
SCHEMBL27884477 0.80 PHGDH (0.44) ACLYCCR2PHGDHCSNK2A2CSNK2B
SCHEMBL28797215 0.80 DHCR7 (0.41) ACLYPHGDHCSNK2A2CSNK2BCSNK2A1
SCHEMBL28800057 0.80 ACLY (0.43) ACLYCCR2PHGDHCA1CA2
SCHEMBL27713455 0.78 PPARG (0.54) ACLYNPC1RAB9ASMN1; SMN2PPARG
SCHEMBL27884471 0.77 ACLY (0.37) ACLYCCR2PHGDHPPARGPPARD
SCHEMBL27733850 0.76 PPARG (0.56) PPARGPPARDPPARA
SCHEMBL28946031 0.74 ACLY (0.35) ACLYPHGDHSMN1; SMN2PPARGPPARD
SCHEMBL27884203 0.74 PPARG (0.34) ACLYCCR2PHGDHPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102596906-A Use of indole derivatives as NURR-1 activators as agents for the treatment of Parkinson's disease FOURNIER LAB SA 2012-07-18 — — CN disclosed
Send feedback